Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity
In this study, we focused on innovative approaches to improve drug administration in oral
pathology, especially by transmucosal and transdermal pathways. These improvements …
pathology, especially by transmucosal and transdermal pathways. These improvements …
MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer
R Dinami, L Pompili, E Petti, M Porru… - EMBO Molecular …, 2023 - embopress.org
The telomeric repeat‐binding factor 2 (TRF2) is a telomere‐capping protein that plays a key
role in the maintenance of telomere structure and function. It is highly expressed in different …
role in the maintenance of telomere structure and function. It is highly expressed in different …
Unlocking new dimensions in rheumatoid arthritis therapy: Harnessing the power of lipid based vesicles beyond traditional therapies
R Bahuguna, R Awasthi - Journal of Drug Delivery Science and Technology, 2023 - Elsevier
Rheumatoid arthritis (RA) is a persistent and chronic joint disease characterized by the
formation of autoantibodies that develop a local immune response at the synovial …
formation of autoantibodies that develop a local immune response at the synovial …
Controlled production of liposomes with novel microfluidic membrane emulsification for application of entrapping hydrophilic and lipophilic drugs
L Zhang, H Zhu, P Ye, L Zhu, Y Ren, J Lei - Journal of Industrial and …, 2024 - Elsevier
In view of the limitations in the reported methods for the preparation of liposomes, a new
microfluidic membrane emulsification device was innovatively designed and fabricated to …
microfluidic membrane emulsification device was innovatively designed and fabricated to …
[HTML][HTML] Solid lipid nanoparticles
TTL Nguyen, VA Duong - Encyclopedia, 2022 - mdpi.com
Definition Solid lipid nanoparticles (SLNs) are produced from physiologically biocompatible
lipids. They have been proven to improve solubility, cellular uptake, and stability, reduce …
lipids. They have been proven to improve solubility, cellular uptake, and stability, reduce …
[HTML][HTML] Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines
DH Zimmerman, Z Szekanecz, A Markovics… - Frontiers in …, 2024 - frontiersin.org
Rheumatoid arthritis (RA) is recognized as an autoimmune joint disease driven by T cell
responses to self (or modified self or microbial mimic) antigens that trigger and aggravate …
responses to self (or modified self or microbial mimic) antigens that trigger and aggravate …
[HTML][HTML] Lipid nano-system based topical drug delivery for management of rheumatoid arthritis: an overview
KD Dhule, TD Nandgude - Advanced Pharmaceutical Bulletin, 2023 - ncbi.nlm.nih.gov
The overall purpose of rheumatoid arthritis (RA) treatment is to give symptomatic alleviation;
there is no recognized cure for RA. Frequent use of potent drugs like non-steroidal anti …
there is no recognized cure for RA. Frequent use of potent drugs like non-steroidal anti …
Programmable Bionanomaterials for revolutionizing cancer immunotherapy
Cancer immunotherapy involves a cutting-edge method that utilizes the immune system to
detect and eliminate cancer cells. It has shown substantial effectiveness in treating different …
detect and eliminate cancer cells. It has shown substantial effectiveness in treating different …
[HTML][HTML] Comparative In Vitro Study between Biocompatible Chitosan-Based Magnetic Nanocapsules and Liposome Formulations with Potential Application in Anti …
G Vochița, AN Cadinoiu, DM Rață… - International Journal of …, 2024 - mdpi.com
This study describes the comparison between the interaction of a series of peptide-
functionalized chitosan-based nanocapsules and liposomes with two cell lines, ie, mouse …
functionalized chitosan-based nanocapsules and liposomes with two cell lines, ie, mouse …
Current strategies and potential prospects for nanoparticle-mediated treatment of diabetic nephropathy
C Liu, K Wu, H Gao, J Li, X Xu - Diabetes, Metabolic Syndrome …, 2022 - Taylor & Francis
Diabetic nephropathy (DN), a severe microvascular complication of diabetes mellitus (DM),
is the most common form of chronic kidney disease (CKD) and a leading cause of renal …
is the most common form of chronic kidney disease (CKD) and a leading cause of renal …